Entity
  • QIMA Life Sciences

    Created in 1996


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    7,297
  • Activities

  • Technologies

  • Entity types

  • Location

    Rue des Plantes, 86160 Gençay, France

    Gençay

    France

  • Employees

    Scale: 11-50, 51-200

    Estimated: 102

  • SIREN

    407675628
  • Engaged catalyst

    5
    0 0
  • Added in Motherbase

    4 years, 5 months ago
Description
  • Value proposition

    QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology.
    We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays.
    QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations.
    QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D departments to innovate in the field of project conceptualization and to substantiate and support their product claims.

    Contact us at: ls@qima.com

    Cosmetology, Neurobiology, Dermatology, Inflammation & immunity, Others (osteo-articular, cancer, metabolic diseases, stress, aging), Pharmacology, Veterinary medecine, Medical devices, Clinical imaging, Imaging solutions, Hair research, Trichology, Hair follicle, Nutraceutical, in vitro, ex vivo & in vivo models, and Pre-clinical and clinical research

  • Original language

    QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology.
    We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays.
    QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations.
    QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D departments to innovate in the field of project conceptualization and to substantiate and support their product claims.

    Contact us at: ls@qima.com

  • Preclinical research CRO, in vitro bioassays - QIMA Life Sciences

    Preclinical CRO for pharmacology, dermatology and cosmetics, in vitro models and bioassays alternative methods to animal testing.

  • https://qima-lifesciences.com/
Catalyst interactions
Catalyst TypeTweets Articles
Eurobiomed
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

23 Apr 2025


LVMH
LVMH
Luxury, Retail Luxury Goods and Jewelry
LVMH
Luxury, Retail Luxury Goods and Jewelry
Other

21 Sep 2023


CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services
Other

25 May 2023


L'Oréal
L'Oréal
Cosmetics, Personal Care Product Manufacturing
L'Oréal
Cosmetics, Personal Care Product Manufacturing
Other

16 Feb 2023


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

12 Mar 2025


Social network dynamics
Similar entities
BETA
Loading...
Loading...